Search Results for "Pradaxa"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Pradaxa. Results 21 to 25 of 25 total matches.
See also: dabigatran
Treatment of Atrial Fibrillation
The Medical Letter on Drugs and Therapeutics • Jan 08, 2024 (Issue 1693)
— The direct oral
anticoagulants (DOACs) dabigatran (Pradaxa, and
generics), rivaroxaban (Xarelto), apixaban ...
Atrial fibrillation (AF) is the most common arrhythmia
in the world. Risk factor modification, anticoagulation,
rhythm control, and rate control are the four pillars
of its management. American College of Cardiology/American Heart Association (ACC/AHA) guidelines
on management of AF were updated recently.
Med Lett Drugs Ther. 2024 Jan 8;66(1693):1-8 doi:10.58347/tml.2024.1693a | Show Introduction Hide Introduction
Daclatasvir (Daklinza) for HCV Genotype 3 Infection
The Medical Letter on Drugs and Therapeutics • Oct 12, 2015 (Issue 1479)
of these transporters, such as digoxin
(Lanoxin, and others), the anticoagulant dabigatran
(Pradaxa), or statins ...
The FDA has approved daclatasvir (Daklinza – BMS),
an oral direct-acting antiviral drug, for use with
sofosbuvir (Sovaldi) for treatment of chronic hepatitis
C virus (HCV) genotype 3 infection. Daclatasvir is
the first drug approved for this indication that does
not require the addition of interferon or ribavirin. It is
approved in Japan and Europe in combination with
other drugs for treatment of HCV genotypes 1-4.
Elagolix (Orilissa) - An Oral GnRH Antagonist for Endometriosis Pain
The Medical Letter on Drugs and Therapeutics • Sep 24, 2018 (Issue 1556)
, such as dabigatran (Pradaxa),
could increase serum concentrations of the substrate.5
Elagolix is also a substrate ...
The FDA has approved elagolix (Orilissa – AbbVie),
an oral gonadotropin-releasing hormone (GnRH)
antagonist, for management of moderate to severe
pain associated with endometriosis.
Lipid-Lowering Drugs
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
are at increased risk for
muscular adverse effects.10
In patients taking dabigatran etexilate (Pradaxa ...
Cholesterol management guidelines from the
American College of Cardiology/American Heart
Association Task Force were last published in 2019.
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
increase the risk of major hemorrhage
in patients taking dabigatran etexilate (Pradaxa); mechanism ...
View the Comparison Table: Some Lipid-Lowering Drugs